Literature DB >> 16816023

Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems.

F Malfait, S Symoens, P Coucke, L Nunes, S De Almeida, A De Paepe.   

Abstract

BACKGROUND: Heterozygous mutations in the COL1A1 or COL1A2 gene encoding the alpha1 and alpha2 chain of type I collagen generally cause either osteogenesis imperfecta or the arthrochalasis form of Ehlers-Danlos syndrome (EDS). Homozygous or compound heterozygous COL1A2 mutations resulting in complete deficiency of the proalpha2(I) collagen chains are extremely rare and have been reported in only a few patients, albeit with variable phenotypic outcome.
METHODS: The clinical features of the proband, a 6 year old boy, were recorded. Analysis of proalpha and alpha-collagen chains was performed by SDS-polyacrylamide gel electrophoresis using the Laemmli buffer system. Single stranded conformation polymorphism analysis of the proband's DNA was also carried out.
RESULTS: In this report we show that complete lack of proalpha2(I) collagen chains can present as a phenotype reminiscent of mild hypermobility EDS during childhood.
CONCLUSIONS: Biochemical analysis of collagens extracted from skin fibroblasts is a powerful tool to detect the subset of patients with complete absence of proalpha2(I) collagen chains, and in these patients, careful cardiac follow up with ultrasonography is highly recommended because of the risk for cardiac valvular problems in adulthood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816023      PMCID: PMC2564565          DOI: 10.1136/jmg.2005.038224

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro(alpha)2(I) chain and an EDS/OI clinical phenotype.

Authors:  A C Nicholls; D Valler; S Wallis; F M Pope
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

Review 2.  A perfect message: RNA surveillance and nonsense-mediated decay.

Authors:  M W Hentze; A E Kulozik
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

3.  Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome.

Authors:  Manon C Zweers; Jim Bristow; Peter M Steijlen; Willow B Dean; Ben C Hamel; Marisol Otero; Martina Kucharekova; Jan B Boezeman; Joost Schalkwijk
Journal:  Am J Hum Genet       Date:  2003-07       Impact factor: 11.025

4.  Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).

Authors:  P Beighton; A De Paepe; B Steinmann; P Tsipouras; R J Wenstrup
Journal:  Am J Med Genet       Date:  1998-04-28

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Biochemical heterogeneity of osteogenesis imperfecta: New variant.

Authors:  A C Nicholls; F M Pope; H Schloon
Journal:  Lancet       Date:  1979-06-02       Impact factor: 79.321

7.  The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.

Authors:  S B Deak; A Nicholls; F M Pope; D J Prockop
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

8.  Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene.

Authors:  A Schnieke; K Harbers; R Jaenisch
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

9.  Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway.

Authors:  Ulrike Schwarze; Ryu-Ichiro Hata; Victor A McKusick; Hiroshi Shinkai; H Eugene Hoyme; Reed E Pyeritz; Peter H Byers
Journal:  Am J Hum Genet       Date:  2004-04-09       Impact factor: 11.025

10.  Prevalence of aortic root dilation in the Ehlers-Danlos syndrome.

Authors:  Richard J Wenstrup; Richard A Meyer; Jennifer S Lyle; Leah Hoechstetter; Peter S Rose; Howard P Levy; Claire A Francomano
Journal:  Genet Med       Date:  2002 May-Jun       Impact factor: 8.822

View more
  37 in total

1.  Genes in thoracic aortic aneurysms/dissections - do they matter?

Authors:  Julie De Backer; Laurence Campens; Anne De Paepe
Journal:  Ann Cardiothorac Surg       Date:  2013-01

Review 2.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

3.  Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease.

Authors:  Jonathan D Cheek; Elaine E Wirrig; Christina M Alfieri; Jeanne F James; Katherine E Yutzey
Journal:  J Mol Cell Cardiol       Date:  2012-01-10       Impact factor: 5.000

Review 4.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

5.  The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite.

Authors:  Laurence H Arnold; Louise E Butt; Stephen H Prior; Christopher M Read; Gregg B Fields; Andrew R Pickford
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

Review 6.  The triple helix of collagens - an ancient protein structure that enabled animal multicellularity and tissue evolution.

Authors:  Aaron L Fidler; Sergei P Boudko; Antonis Rokas; Billy G Hudson
Journal:  J Cell Sci       Date:  2018-04-09       Impact factor: 5.285

Review 7.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

8.  Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance.

Authors:  Jacqueline D Peacock; Yinhui Lu; Manuel Koch; Karl E Kadler; Joy Lincoln
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

9.  Mouse chromosome 17 candidate modifier genes for thrombosis.

Authors:  Qila Sa; Erika Hart; Joseph H Nadeau; Jane L Hoover-Plow
Journal:  Mamm Genome       Date:  2010-08-11       Impact factor: 2.957

10.  Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.

Authors:  Sejin Han; Elena Makareeva; Natalia V Kuznetsova; Angela M DeRidder; Mary Beth Sutter; Wolfgang Losert; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.